Vaccination for a 16-Year-Old Female
Yes, a healthy 16-year-old female should receive all routine vaccines recommended for adolescents, including HPV, meningococcal (both MenACWY and potentially MenB), Tdap (if not previously received), influenza annually, and COVID-19 vaccines. 1
Routine Vaccines Recommended at Age 16
HPV Vaccine
- HPV vaccination is strongly recommended through age 26 years for females who have not completed the series. 1
- The vaccine protects against HPV types 6,11,16,18,31,33, and others depending on formulation (nonavalent HPV vaccine is now standard). 1
- A complete series consists of 3 doses: second dose 2 months after the first, third dose 6 months after the first (minimum 24 weeks). 1
- If the series was started at ages 9-14 years, only 2 doses may be needed; if started at age 15 or older, 3 doses are required. 1
Meningococcal Vaccines
- MenACWY booster dose is specifically recommended at age 16 years if the first dose was given at age 11-12 years. 1
- MenB vaccine may be administered to adolescents aged 16-23 years (preferred age 16-18 years) based on shared clinical decision-making to provide short-term protection against serogroup B meningococcal disease. 1
- MenB requires a 2-dose series, and the two available products (MenB-4c and MenB-FHbp) are not interchangeable once the series is started. 1
- Both MenACWY and MenB can be given during the same visit using different injection sites. 1
Tdap Vaccine
- If not previously received, Tdap should be administered as a one-time dose to replace the routine Td booster. 1
- Tdap is recommended for all adolescents aged 13-18 years who have not received it. 1
Influenza Vaccine
- Annual influenza vaccination is recommended for all adolescents. 1
- Only inactivated influenza vaccine (IIV) should be used for adolescents with certain medical conditions; otherwise, either IIV or live attenuated influenza vaccine (LAIV) is acceptable. 1
COVID-19 Vaccine
- COVID-19 vaccination is recommended for all adolescents aged 16 years and older. 1
- The number of doses and intervals depend on previous vaccination history and the specific vaccine product used. 1
- Updated booster doses should be administered according to current CDC guidance. 1
Catch-Up Vaccination Considerations
If the patient is not up to date with childhood vaccines, assess and administer catch-up doses for:
- Hepatitis B (3-dose series if not completed). 1
- Hepatitis A (2-dose series). 2
- MMR (2 doses if not documented). 1
- Varicella (2 doses if no history of disease or vaccination). 1
Important Clinical Considerations
Timing and Co-administration
- Multiple vaccines can be administered during the same visit at different anatomical sites. 1
- Starting HPV vaccination before or concurrent with other adolescent vaccines improves series completion rates compared to delaying HPV after Tdap or meningococcal vaccines. 3
Common Pitfalls to Avoid
- Do not delay HPV vaccination - it can be given starting at age 9 and should not wait until after other adolescent vaccines. 3
- Do not forget the MenACWY booster at age 16 - this is a specific recommendation for this age group. 1
- MenB vaccines are not interchangeable - complete the series with the same product. 1
- Review vaccination records carefully - many adolescents have incomplete series that need catch-up doses. 4, 5
Special Populations
- For immunocompromised adolescents (including HIV infection), vaccines may still be administered but immune response may be reduced. 1
- Pregnancy is a contraindication to live vaccines (MMR, varicella, LAIV) but not to inactivated vaccines. 1, 6
Coverage Data Context
Recent surveillance shows that among 16-17 year olds in the United States:
- 91.3% have received ≥1 Tdap dose
- 90.1% have received ≥1 MenACWY dose
- 78.2% have received ≥1 HPV dose, but only 62.9% are up to date with the series 4
These data emphasize the ongoing need to ensure adolescents complete recommended vaccine series, particularly HPV vaccination. 4, 5